BioCorteX
BioCorteX builds an emulator that predicts how a patient’s bacteria and immune system influence drug effectiveness. Their Carbon Mirror platform combines the Carbon Knowledge biology knowledge graph with AI models and biology data to simulate drug–bacteria interactions in the tumor microenvironment. Offered as a SaaS to pharmaceutical companies and researchers, the platform supports in silico trials, clinical trial design optimization, and therapeutic stratification. By surfacing microbiome-driven variability, BioCorteX aims to de-risk clinical programs and enable more targeted drug development at scale.
BioCorteX
BioCorteX builds an emulator that predicts how a patient’s bacteria and immune system influence drug effectiveness. Their Carbon Mirror platform combines the Carbon Knowledge biology knowledge graph with AI models and biology data to simulate drug–bacteria interactions in the tumor microenvironment. Offered as a SaaS to pharmaceutical companies and researchers, the platform supports in silico trials, clinical trial design optimization, and therapeutic stratification. By surfacing microbiome-driven variability, BioCorteX aims to de-risk clinical programs and enable more targeted drug development at scale.